Final Program

SUNDAY • MAY 15 53
Facilitator:
P715
P716
P717
P718
P719
P720
A38
B.M. Morrissey, MD, Sacramento, CA
PB01: A Recombinant Human Follistatin Protein for the
Treatment of Neutrophilic Lung Diseases/B.M. Kita, C.L. Hardy,
R.E. O’Hehir, M. Hedger, D.M. De Kretser, Caulfield North,
Australia, p.A1413
CF Airway Epithelia Contribute to the Compromised Innate
Immunity Against Bacterial Infection/X. Yang, V. Patel, M.
Wang, D.D. Thomas, L.L. Mantell, Jamaica, NY, p.A1414
Altered Phagosomal Degranulation in Neutrophils of
Individuals with Cystic Fibrosis; an Impairment Corrected by
CFTR Potential Therapy/N. Browne, F. Gargoum, P. Hawkins, E.
Reeves, N.G. McElvaney, Dublin, Ireland, p.A1415
Use of the Basophil Surface Marker CD203c in the
Identification of Aspergillus Fumigatus Sensitisation in Cystic
Fibrosis/G.M. Lavelle, B. Mirkovic, A.A. Azim, K. Helma, F.
Gargoum, K. Molloy, Y. Gernez, K. Dunne, J. Renwick, P. Murphy,
C.M. Greene, R.B. Moss, C. Gunaratnam, S.H. Chotirmall, N.G.
McElvaney, Dublin, Ireland, p.A1416
The Metalloprotease LasB from Pseudomonas Aeruginosa
Subverts Innate Immunity In Vitro and In Vivo/J.-M. Sallenave,
V. Saint-Criq, F. Bastaert, B. Villeret, A. Hatton, A. Edelman, Paris,
France, p.A1417
Electrolyte Transport Properties in Distal Small Airways from
Cystic Fibrosis Pigs with Implications for Host Defense/X. Li,
X.X. Tang, L.G. Vargas Buonfiglio, P. Karp, P. Taft, K. Sheets, M.
Welsh, D. Stoltz, J. Zabner, Coralville, IA, p.A1418
THEMATIC POSTER SESSION
DIAGNOSTIC MARKERS OF ASTHMA AND COPD
9:00 a.m. - 4:15 p.m. MOSCONE CENTER
Viewing: Posters will be on display for entire session.
Area B, Hall D (North Building, Lower Level)
Discussion: 11:00-11:45: authors will be present for individual discussion
11:45-12:45: authors will be present for discussion with assigned facilitators
Facilitator:
P135
P136
P137
M.R. Stampfli, PhD, Hamilton, Canada
Cluster Analysis of Asthma Patients with Allergic Rhinitis
Including Rhinitis Symptoms and Serum Periostin Levels as
Variable/N. Sugimoto, H. Nagase, M. Kinoshita, H. Sakasegawa,
T. Esaki, M. Ohsumi, Y. Koizumi, Y. Tanaka, S. Ro, H. Yoshihara,
M. Kuramochi, H. Arai, M. Yamaguchi, K. Izuhara, K. Ohta, Tokyo,
Japan, p.A1419
Reference Ranges for Serum Periostin in a Population Without
Asthma or COPD/I. Braithwaite, R. Caswell-Smith, A. Hosking, T.
Cripps, C. Holweg, J. Matthews, M. Holliday, C. Maillot, J. Fingleton,
M. Weatherall, R. Beasley, Wellington, New Zealand, p.A1420
Sinus Computed Tomographic Findings in Smoking and
Non-Smoking Asthmatics: Associations with Asthma-Related
Indices and Biomarkers Analysis/H. Kimura, S. Konno, Y.
Nakamaru, H. Makita, N. Taniguchi, K. Shimizu, M. Suzuki, J. Ono,
K. Izuhara, M. Nishimura, Sapporo, Japan, p.A1421
P138
P139
P140
P141
P142
Facilitator:
P143
P144
P145
P146
P147
P148
Multi-Level Differential Network Analysis of COPD
Exacerbations/R. Faner, G. Noell, B.G. Cosio, T. Casserras, I.
Coca, E. Monso, G. Peces-Barba, A. De Diego, C. Esteban, J.
Gea, S. Kalko, A. Agusti, Barcelona, Spain, p.A1422
The Relative Importance of av-Integrins in Chronic
Obstructive Pulmonary Disease/C. Moermans, H. Lou, O.J.
Brand, A. Cormier, A. Bondesson, P.J. Wolters, D. Jablons, L.
Murray, S. Nishimura, San Francisco, CA, p.A1423
Discovery of Non-Invasive Biomarkers of IL-17 Activity from
Experimental Models of Asthma/M. Bremer, D. Choy, G. Jia, D.
Nagarkar, S. Kotwal, W. Lee, A. Abbas, F. Cai, J. Arron, H.
Scheerens, T. Staton, South San Francisco, CA, p.A1424
Different Pathways of Inflammasome Activation in Human
Precision-Cut Lung Slices (PCLS)/S. Konzok, P. Braubach, D.
Peter, D. Jonigk, H.-G. Fieguth, A. Braun, K. Sewald, Hannover,
Germany, p.A1425
Biomarker Characterization of a Debilitated Phenotype in
SPIROMICS/I. Barjaktarevic, C.H. Martinez, J.L. Curtis, R.P.
Bowler, W.K. O'Neal, E.A. Hoffman, E.E. Carretta, M. Quibrera,
R.G. Barr, E. Bleecker, D.J. Couper, G.J. Criner, M.T. Dransfield,
M.K. Han, N.N. Hansel, R. Kanner, S.C. Lazarus, F.J. Martinez, R.
Paine, III, D.P. Tashkin, P.G. Woodruff, C.B. Cooper, Los Angeles,
CA, p.A1426
S.M. Lyon, MD, Philadelphia, PA
Cigarette Smoke and Cigarette Smoke Condensate Induce
Early Biomarkers of Inflammation and Cytotoxicity in
Precision-Cut Lung Slices/H. Obernolte, D. Ritter, J.W. Knebel,
P. Braubach, D. Jonigk, H.-G. Fieguth, A. Braun, K. Sewald,
Hannover, Germany, p.A1427
Evaluation of Th2 and Th17 Cytokine Levels in Serum from
Asthmatics Using the High Sensitivity Quanterix Simoa HD-1
Platform/M.L. Gavala, D. Smith, South San Francisco, CA, p.A1428
Airway Inflammation and Clinical Manifestations in Patients
with Mild Asthma: Time Course of Human Rhinovirus (HRV)
Induced Changes/J. Efthimiou, A. Mann, G. Balaratnam, J.
Gunter, P. Rucki, C. Poll, M. Johnson, T. Lockett, London, United
Kingdom, p.A1429
What Are the Priorities for Future Research into Diagnostic
Tools for Asthma? A Pan-EU Consensus Exercise/L.
Garcia-Marcos, J.L. Edwards, E.J. Kennington, S. Walker, Murcia,
Spain, p.A1430
Multidimensional Analysis of Human Lung Myeloid Cells
Reveal Unique Subpopulations in COPD and IPF/J.J. Atkinson,
B.C. Keller, D.G. Kelley, X. Jin, R.M. Senior, R.M. Presti, D.E.
Byers, St. Louis, MO, p.A1431
Current Smoking Increases Macrophage Numbers and
Immunoregulatory Receptor Expression in Bronchoalveolar
Lavage but not Sputum in Chronic Obstructive Pulmonary
Disease: SPIROMICS Immunophenotyping Sub-Study/
J.P. Brown, C.M. Freeman, S.W. Crudgington, V.R. Stolberg, J.
Sonstein, N.E. Alexis, P.V. Basta, E.E. Carretta, S. Christenson,
D.J. Couper, C.M. Doerschuk, N.N. Hansel, M.K. Han, A.T. Hastie,
R.J. Kaner, F.J. Martinez, W.K. O'Neal, R. Paine, III, S.I. Rennard,
D. Shimbo, P.G. Woodruff, M. Zeidler, J.L. Curtis, Ann Arbor, MI,
p.A1432
SUNDAY MORNING
ATS 2016 • San Francisco